Tilray Brands (NASDAQ:TLRY) is a global pioneer in the cultivation, production and distribution of cannabis and hemp-derived products, alongside a growing portfolio of beverage alcohol and wellness offerings. The company’s core operations span medical and adult-use cannabis markets, where it develops and markets a diverse range of products including dried flower, oils, capsules, vapes and topicals. With an integrated supply chain that encompasses breeding, extraction, formulation and packaging, Tilray Brands serves patients, adult-use consumers and retailers across North America, Europe, Latin America and Australia.
Originally founded in 2013 in Nanaimo, British Columbia by a team including Brendan Kennedy, John-Andrew Fowler and David J. Martin, the company went public on the Nasdaq in 2018. In May 2021, Tilray merged with Aphria Inc., creating Tilray Brands, Inc., one of the largest global cannabis companies by production capacity and market reach. The combination brought together Aphria’s leadership in beverage alcohol distribution and Tilray’s international cannabis network, establishing a diversified consumer products company listed on the Nasdaq under the ticker TLRY.
Tilray Brands’ product suite extends beyond cannabis into beverage alcohol through craft beer and spirits brands such as SweetWater Brewing Company, Breckenridge Brewery, Montucky Cold Snacks and a line of low-calorie malt beverages. On the wellness front, the company markets hemp-based foods and nutritional products under brands like Manitoba Harvest. Across all categories, Tilray emphasizes research-driven innovation, quality control and compliance with local regulations to support patient care, adult-use markets and retail partners.
Headquartered in New York, Tilray Brands employs a leadership team led by CEO Irwin D. Simon and supported by executives with deep experience in consumer packaged goods, pharmaceuticals and regulated industries. The company operates production facilities in Canada, Portugal, Germany, Australia and Latin America, and holds licenses to distribute medical and adult-use cannabis in more than 20 countries. Tilray Brands continues to pursue strategic partnerships, research collaborations and targeted acquisitions to drive growth and innovation in emerging regulated markets.
